CDK inhibitors and their use as pharmaceuticals

The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

Saved in:
Bibliographic Details
Main Authors Bersch, Klare Lazor, Combs, Andrew Paul, Shetty, Rupa, Dai, Chaofeng, Leal, Raul Andrew, Lu, Liang
Format Patent
LanguageEnglish
Published 13.06.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.
AbstractList The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.
Author Lu, Liang
Shetty, Rupa
Dai, Chaofeng
Leal, Raul Andrew
Bersch, Klare Lazor
Combs, Andrew Paul
Author_xml – fullname: Bersch, Klare Lazor
– fullname: Combs, Andrew Paul
– fullname: Shetty, Rupa
– fullname: Dai, Chaofeng
– fullname: Leal, Raul Andrew
– fullname: Lu, Liang
BookMark eNrjYmDJy89L5WTQd3bxVsjMy8hMyizJLypWSMxLUSjJSM0sUigtTlVILFYoyEgsyk1MTi0tyUxOzCnmYWBNA1KpvFCam0HRzTXE2UM3tSA_PrW4AKgyL7UkPjTY0NDM3NjC0tjJyJgYNQDyACyH
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US11673893B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11673893B23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:21:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11673893B23
Notes Application Number: US202017018005
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230613&DB=EPODOC&CC=US&NR=11673893B2
ParticipantIDs epo_espacenet_US11673893B2
PublicationCentury 2000
PublicationDate 20230613
PublicationDateYYYYMMDD 2023-06-13
PublicationDate_xml – month: 06
  year: 2023
  text: 20230613
  day: 13
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Prelude Therapeutics Incorporated
RelatedCompanies_xml – name: Prelude Therapeutics Incorporated
Score 3.468971
Snippet The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CDK inhibitors and their use as pharmaceuticals
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230613&DB=EPODOC&locale=&CC=US&NR=11673893B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1LS8Mw-GNMUW86FZ0PIkhvZatp2nooQtuVoeyBW2W30bQp6w612A7_vl9C53ZRcgkJ5PHB934BPNrcsbhtML3PYqGbBqe6k4lMt56ZmTLmcNOUCc6jsTWMzNcFW7Rgvc2FUXVCv1VxRMSoBPG9VvS63BmxAhVbWfV4jkufL-HcDbRGO5bytEG1wHMH00kw8TXfd6OZNn53pbtB8mYPyfUBitG2Uto-PJmVUu6zlPAUDqd4WlGfQUsUHTj2t53XOnA0ahzeOG1wrzqHnh-8kbxY5TyXHXJIXKREmfnJphIkrki52jdPVxfwEA7m_lDHm5e_31xGs90j6SW0Uf0XV0DSjLLM6Wd2YqM0LxB8GTccjiOhpqBP19D9-5zuf5s3cCJBJgOfDHoL7fprI-6Qxdb8XsHmB7Owf-U
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1LS8Mw-GNMcd50Km6-IkhvZatp1noowtqV6p64VnYrzZayeqjDdvj3_RI2t4uSS0ggjw--9wvgweJ2h1sG09ssEbppcKrbqUj1zhMzF4zZ3DRlgvNw1Aki83XGZhX42ObCqDqh36o4ImLUHPG9VPR6tTNieSq2smjxDJc-n_3Q8bSNdizlaYNqXtfpTcbe2NVc14mm2ujNke4GyZu7SK4PUMS2lar03pVZKat9luKfwOEET8vLU6iIvA41d9t5rQ5Hw43DG6cb3CvOoOV6fZLly4xnskMOSfIFUWZ-si4ESQqyWu6bp4tzuPd7oRvoeHP8-804mu4eSS-giuq_uASySClL7XZqzS2U5gWCL-WGzXHMqSnoYwOaf5_T_G_zDmpBOBzEg5dR_wqOJfhkEJRBr6Fafq3FDbLbkt8qOP0A2riC1Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CDK+inhibitors+and+their+use+as+pharmaceuticals&rft.inventor=Bersch%2C+Klare+Lazor&rft.inventor=Combs%2C+Andrew+Paul&rft.inventor=Shetty%2C+Rupa&rft.inventor=Dai%2C+Chaofeng&rft.inventor=Leal%2C+Raul+Andrew&rft.inventor=Lu%2C+Liang&rft.date=2023-06-13&rft.externalDBID=B2&rft.externalDocID=US11673893B2